CD274 and neoplasm: Programmed cell death 1 ligand 1 (PD-L1) expression was analyzed in 44/264 (16.67%) of primary tumor samples, and the mean PD-L1 expression was graded 45.35% in tumor cells (range 0%–90%) and 3.26% on infiltrating immune cells (range 0%–20%).